- Home
- CRVS vs VGM Comparison
CRVS vs VGM Comparison
Compare CRVS & VGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- VGM
- Stock Information
- Founded
- CRVS 2014
- VGM 1992
- Country
- CRVS United States
- VGM United States
- Employees
- CRVS N/A
- VGM N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- VGM Trusts Except Educational Religious and Charitable
- Sector
- CRVS Health Care
- VGM Finance
- Exchange
- CRVS Nasdaq
- VGM Nasdaq
- Market Cap
- CRVS 459.0M
- VGM 543.9M
- IPO Year
- CRVS 2016
- VGM N/A
- Fundamental
- Price
- CRVS $7.59
- VGM $10.22
- Analyst Decision
- CRVS Strong Buy
- VGM
- Analyst Count
- CRVS 4
- VGM 0
- Target Price
- CRVS $13.75
- VGM N/A
- AVG Volume (30 Days)
- CRVS 1.0M
- VGM 186.2K
- Earning Date
- CRVS 11-04-2025
- VGM 01-01-0001
- Dividend Yield
- CRVS N/A
- VGM 4.34%
- EPS Growth
- CRVS N/A
- VGM N/A
- EPS
- CRVS N/A
- VGM 0.01
- Revenue
- CRVS N/A
- VGM N/A
- Revenue This Year
- CRVS N/A
- VGM N/A
- Revenue Next Year
- CRVS N/A
- VGM N/A
- P/E Ratio
- CRVS N/A
- VGM $988.00
- Revenue Growth
- CRVS N/A
- VGM N/A
- 52 Week Low
- CRVS $2.54
- VGM $8.15
- 52 Week High
- CRVS $10.00
- VGM $10.07
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- VGM 62.30
- Support Level
- CRVS $6.81
- VGM $10.06
- Resistance Level
- CRVS $7.96
- VGM $10.18
- Average True Range (ATR)
- CRVS 0.52
- VGM 0.08
- MACD
- CRVS -0.03
- VGM -0.01
- Stochastic Oscillator
- CRVS 67.50
- VGM 84.62
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About VGM Invesco Trust for Investment Grade Municipals (DE)
Invesco Trust for Investment Grade Municipals is active in the financial services sector. Its investment objective is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.